Open AccessNeoadjuvant pyrotinib plus trastuzumab and nab-paclitaxel for HER2-positive early or locally advanced breast cancer: an exploratory phase II trial
Author(s) -
Xiaorong Zhong,
Ping He,
Jie Chen,
Xi Yan,
Bin Wei,
Zhang Zhang,
Hong Bu,
Jing Li,
Tinglun Tian,
Qing Lv,
Xiaodong Wang,
Hongjiang Li,
Jing Wang,
Juan Huang,
Jiaojiao Suo,
Xiaoxiao Liu,
Hong Zheng,
Ting Luo
Publication year - 2022
Publication title -
gland surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.643
H-Index - 22
eISSN - 2227-8575
pISSN - 2227-684X
DOI - 10.21037/gs-21-911
Subject(s) - medicine , trastuzumab , tolerability , breast cancer , adverse effect , paclitaxel , oncology , clinical endpoint , phases of clinical research , neoadjuvant therapy , response evaluation criteria in solid tumors , gastroenterology , cancer , chemotherapy , clinical trial
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom